Correlation Between MorphoSys and Vaxcyte

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MorphoSys and Vaxcyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MorphoSys and Vaxcyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MorphoSys AG ADR and Vaxcyte, you can compare the effects of market volatilities on MorphoSys and Vaxcyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MorphoSys with a short position of Vaxcyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of MorphoSys and Vaxcyte.

Diversification Opportunities for MorphoSys and Vaxcyte

0.34
  Correlation Coefficient

Weak diversification

The 3 months correlation between MorphoSys and Vaxcyte is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding MorphoSys AG ADR and Vaxcyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaxcyte and MorphoSys is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MorphoSys AG ADR are associated (or correlated) with Vaxcyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaxcyte has no effect on the direction of MorphoSys i.e., MorphoSys and Vaxcyte go up and down completely randomly.

Pair Corralation between MorphoSys and Vaxcyte

Considering the 90-day investment horizon MorphoSys AG ADR is expected to under-perform the Vaxcyte. In addition to that, MorphoSys is 4.81 times more volatile than Vaxcyte. It trades about -0.18 of its total potential returns per unit of risk. Vaxcyte is currently generating about 0.03 per unit of volatility. If you would invest  7,694  in Vaxcyte on September 29, 2024 and sell it today you would earn a total of  403.00  from holding Vaxcyte or generate 5.24% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy22.22%
ValuesDaily Returns

MorphoSys AG ADR  vs.  Vaxcyte

 Performance 
       Timeline  
MorphoSys AG ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MorphoSys AG ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, MorphoSys is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.
Vaxcyte 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vaxcyte has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

MorphoSys and Vaxcyte Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MorphoSys and Vaxcyte

The main advantage of trading using opposite MorphoSys and Vaxcyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MorphoSys position performs unexpectedly, Vaxcyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxcyte will offset losses from the drop in Vaxcyte's long position.
The idea behind MorphoSys AG ADR and Vaxcyte pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Money Managers
Screen money managers from public funds and ETFs managed around the world